Please login to the form below

Not currently logged in


This page shows the latest Zynteglo news and features for those working in and with pharma, biotech and healthcare.

FDA starts speedy review of Novartis’ sickle cell antibody

FDA starts speedy review of Novartis’ sickle cell antibody

Bluebird Bio just got its first approval for Zynteglo in transfusion-dependent β-thalassaemia (TDT), another rare blood disease, and already has mid-stage data in hand showing that it can

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...